Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus (Q43048123)

12 November 2017

Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus (English)

1 reference

methicillin-resistant Staphylococcus aureus

12 November 2017

0 references

Staphylococcus aureus

1 reference

Yoojung Yang

1

1 reference

12 November 2017

Martin V McBride

2

1 reference

12 November 2017

Keith A Rodvold

3

1 reference

12 November 2017

Frank Tverdek

4

1 reference

12 November 2017

Anne Marie Trese

5

1 reference

12 November 2017

Joel Hennenfent

6

1 reference

12 November 2017

Gordon Schiff

7

1 reference

12 November 2017

Bruce L Lambert

8

1 reference

12 November 2017

Glen T Schumock

9

1 reference

12 November 2017

1 June 2010

1 reference

American Journal of Health-System Pharmacy

12 November 2017

1 reference

12 November 2017

67

1 reference

12 November 2017

12

1 reference

12 November 2017

1017-1024

1 reference

Antimicrobial resistance: the example of Staphylococcus aureus

12 November 2017

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Management of multidrug-resistant organisms in health care settings, 2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Vancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

The pharmacokinetic and pharmacodynamic properties of vancomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Vancomycin: understanding its past and preserving its future

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Practice guidelines for the management of bacterial meningitis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Adoption of alcohol-based handrub by United States hospitals: a national survey

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Antibiotic cycling or rotation: a systematic review of the evidence of efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

A simplified dosing method for initiating vancomycin therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Pharmacokinetics of vancomycin in patients with various degrees of renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP090563

31 March 2020

Identifiers

DOI

10.2146/AJHP090563

1 reference

12 November 2017

1 reference